Akari Therapeutics Plc (AKTX) Social Stream
AKARI THERAPEUTICS PLC (AKTX) Price Targets From Analysts
Use the tables below to see what analysts covering AKARI THERAPEUTICS PLC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-01 | 1 | $4 | $4 | $4 | $2.89 | 38.41% |
| 2022-12-05 | 1 | $80 | $30 | $55 | $2.89 | 1803.11% |
| NA | 1 | $NA | $NA | $NA | $2.89 | NA% |
Price Target Last Issued NA NA, NA
500 - Internal server error
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|
AKTX Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- AKARI THERAPEUTICS PLC's number of analysts covering the stock is higher than just about none of of all US stocks.
- AKTX has a lower variance in analysts' estimates than -71.24% of all US stocks.
- To contextualize these metrics, consider that out of stocks in the micro market cap category, AKARI THERAPEUTICS PLC's average analyst price target is higher than 214.36% of them.
- In terms of how AKARI THERAPEUTICS PLC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 222.89% of that group.
Stocks similar to AKARI THERAPEUTICS PLC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are PTN, HEPA, and PHIO.
View All Top Stocks by Price Target
Is AKTX a Buy, Hold or Sell? See the POWR Ratings now!